Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHDX

Genomic Health (GHDX) Stock Price, News & Analysis

Genomic Health logo

About Genomic Health Stock (NASDAQ:GHDX)

Advanced Chart

Key Stats

Today's Range
$63.44
$63.44
50-Day Range
$63.44
$69.79
52-Week Range
$50.77
$90.18
Volume
N/A
Average Volume
1.05 million shs
Market Capitalization
$2.38 billion
P/E Ratio
60.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GHDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomic Health and its competitors with MarketBeat's FREE daily newsletter.

GHDX Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
PanGenomic Health Announces CFO Transition
PanGenomic Health Proposes Repricing of Warrants
See More Headlines

GHDX Stock Analysis - Frequently Asked Questions

Genomic Health, Inc. (NASDAQ:GHDX) issued its quarterly earnings results on Monday, November, 11th. The medical research company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.11. Genomic Health had a trailing twelve-month return on equity of 19.62% and a net margin of 12.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genomic Health investors own include Revance Therapeutics (RVNC), Horizon Therapeutics Public (HZNP), Illumina (ILMN), NVIDIA (NVDA), Ionis Pharmaceuticals (IONS), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2019
Today
7/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GHDX
Fax
N/A
Employees
829
Year Founded
N/A

Profitability

Trailing P/E Ratio
60.42
Forward P/E Ratio
40.15
P/E Growth
N/A
Net Income
$25.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$394.11 million
Cash Flow
$1.45 per share
Price / Cash Flow
43.76
Book Value
$7.48 per share
Price / Book
8.48

Miscellaneous

Free Float
N/A
Market Cap
$2.38 billion
Optionable
Optionable
Beta
0.90
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:GHDX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners